{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:41:52Z","timestamp":1774849312568,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms characterized by melanocytic and smooth muscle differentiation. Although the kidney is a relatively common site, malignant renal PEComa is exceedingly rare, particularly in patients with tuberous sclerosis complex (TSC). Overlapping radiologic features between angiomyolipoma and malignant PEComa often result in diagnostic challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report an 18-year-old female who presented with right flank pain. Contrast-enhanced CT revealed a large heterogeneous mass in the right kidney (127 \u00d7 81 mm) with intratumoral hemorrhage, initially interpreted as angiomyolipoma associated with TSC. Physical examination and family history were suggestive of TSC, and genetic testing confirmed a pathogenic TSC2 frameshift mutation. The patient underwent open right partial nephrectomy. Histopathology demonstrated a malignant PEComa composed of epithelioid cells with focal coagulative necrosis. Immunohistochemistry showed diffuse positivity for Melan-A and smooth muscle actin, focal HMB-45 expression, and a Ki-67 index of approximately 5%. The patient recovered postoperatively; however, CT imaging at one-month follow-up revealed a suspected enhancing mass in the lateral mid-portion of the right kidney, requiring continued close surveillance. Based on the suspected enhancing mass identified at the one-month postoperative CT follow-up and the confirmed malignant potential, the patient has been advised to initiate adjuvant mTOR inhibitor therapy (Everolimus). A rigorous 3-month interval follow-up protocol has been established to evaluate treatment efficacy and prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights a rare occurrence of malignant renal PEComa in a young patient with genetically confirmed TSC. Large tumor size, necrosis, and mitotic activity are important indicators of malignant potential. In young patients with TSC and atypical renal masses, malignant PEComa should be considered in the differential diagnosis. Multidisciplinary evaluation, genetic testing, and awareness of emerging mTOR-targeted therapies are essential for optimal management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1790155","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:10:19Z","timestamp":1774843819000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal malignant perivascular epithelioid cell tumor: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Shilong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjin","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2559.2005.02316.x","article-title":"PEComa: what do we know so far","volume":"48","author":"Hornick","year":"2006","journal-title":"Histopathology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3109\/00313029109063563","article-title":"Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney","volume":"23","author":"Pea","year":"1991","journal-title":"Pathol (Phila)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010149","article-title":"Metastatic adrenal PEComa: case report and short review of the literature","volume":"59","author":"Battustella","year":"2023","journal-title":"Med Kaunas Lith"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199710000-00001","article-title":"Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component","volume":"21","author":"Eble","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/PAS.0b013e318161dc34","article-title":"Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum","volume":"32","author":"Hornick","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"30053","DOI":"10.1038\/s41598-025-15340-x","article-title":"Imaging characteristics of renal epithelioid angiomyolipoma and its correlation with risk stratification","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s1607-551x(09)70052-x","article-title":"Epithelioid angiomyolipoma of the kidney mimicking renal cell carcinoma: a clinicopathologic analysis of cases and literature review","volume":"25","author":"Tsai","year":"2009","journal-title":"Kaohsiung J Med Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5301\/jn.2010.5451","article-title":"Renal epithelioid angiomyolipoma: a Malignant disease","volume":"24","author":"Varma","year":"2011","journal-title":"J Nephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e9563","DOI":"10.1097\/MD.0000000000009563","article-title":"Imaging appearance of renal epithelioid angiomyolipoma: A case report and literature review","volume":"97","author":"Zhu","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1794","article-title":"Comprehensive insights into renal perivascular epithelioid cell neoplasms: from molecular mechanisms to clinical practice","volume":"15","author":"Dong","year":"2024","journal-title":"World J Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-022-02277-x","article-title":"Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex","volume":"17","author":"Ritter","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2015.06.003","article-title":"PEComa: morphology and genetics of a complex tumor family","volume":"19","author":"Thway","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2015.02.006","article-title":"PEComas of the kidney and of the genitourinary tract","volume":"32","author":"Martignoni","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2016.02.19","article-title":"Sclerosing perivascular epithelioid cell tumor of the lung: A case report with cytologic findings","volume":"50","author":"Kim","year":"2016","journal-title":"J Pathol Transl Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000173232.22117.37","article-title":"Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature","volume":"29","author":"Folpe","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000002218","article-title":"TFE3 -rearranged PEComa\/PEComa-like neoplasms : report of 25 new cases expanding the clinicopathologic spectrum and highlighting its association with prior exposure to chemotherapy","volume":"48","author":"Argani","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27800","article-title":"Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates","volume":"132","author":"Dickson","year":"2013","journal-title":"Int J Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet Lond Engl"},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13023-018-0781-y","article-title":"Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial","volume":"13","author":"Cai","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B22","article-title":"A retrospective study of patients with Malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience","volume":"34","author":"Benson","year":"2014","journal-title":"Anticancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163705","article-title":"Efficacy of sirolimus treatment in PEComa-10 years of practice perspective","volume":"10","author":"\u015awitaj","year":"2021","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01728","article-title":"nab-sirolimus for patients with Malignant perivascular epithelioid cell tumors","volume":"39","author":"Wagner","year":"2021","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12894-022-01101-9","article-title":"Evaluation of clinicopathological profiles and development of a risk model in renal epithelioid angiomyolipoma patients: a large-scale retrospective cohort study","volume":"22","author":"Anwaier","year":"2022","journal-title":"BMC Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-10-213","article-title":"Malignant epithelioid angiomyolipoma of the kidney with pulmonary metastases and p53 gene mutation","volume":"10","author":"Li","year":"2012","journal-title":"World J Surg Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318206f2a9","article-title":"Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification","volume":"35","author":"Nese","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2024.01.111","article-title":"Malignant perivascular epithelioid cell tumor (PEComa) of kidney","volume":"47","author":"Li","year":"2024","journal-title":"Asian J Surg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2013.11.020","article-title":"A phase ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma","volume":"12","author":"Bitting","year":"2014","journal-title":"Clin Genitourin Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1790155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:10:25Z","timestamp":1774843825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1790155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":29,"alternative-id":["10.3389\/fonc.2026.1790155"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1790155","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"article-number":"1790155"}}